Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success in 2020 ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...

Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...

The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...

US Prosecutors Probe Tip About Timing of Pfizer's COVID Vaccine, WSJ Reports (Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's ...

Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success ... Wednesday GSK’s former head of vaccine development, Philip Dormitzer ...

Investing.com -- Pfizer Inc. (NYSE: PFE) stock fell 1.5% following reports that U.S. prosecutors are investigating a claim ...

(Reuters) -Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot's success ... GSK's former head of vaccine development, Philip Dormitzer ...

Trump has claimed the company delayed an announcement for its vaccine until after the 2020 presidential election.